drug
PERAMPANEL
Marketedupdated 3mo agoby $CPRX CATALYST PHARMACEUTICALS, INC.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(1)
Trials studying PERAMPANEL
- phase2A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
- —An Extended Access Program (EAP) for Perampanel
- phase4A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
- phase2Effect of Perampanel on Peritumoral Hyperexcitability in HGG
- phase1Bioequivalence Study of Perampanel Tablets 12 mg
- phase1Bioequivalence Study of Perampanel Tablets 10 mg
- phase4Perampanel Titration and Cognitive Effects
- phase2Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Patent cliff
source: FDA Orange Bookpatents (7)
- Jul 1, 2026compositionUS 8772497
- Jul 1, 2026compositionUS 8772497
- Jul 1, 2026compositionUS 8772497
- Jul 1, 2026compositionUS 8772497
- Jul 1, 2026compositionUS 8772497
- Jul 1, 2026compositionUS 8772497
- Jul 1, 2026compositionUS 8772497
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that